Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
23.46
+0.75 (3.30%)
At close: Nov 4, 2024, 4:00 PM
22.70
-0.76 (-3.24%)
Pre-market: Nov 5, 2024, 6:00 AM EST
Bicycle Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 36.9 | 26.98 | 14.46 | 11.7 | 10.39 | 13.8 | |
| Revenue Growth (YoY) | 48.60% | 86.52% | 23.65% | 12.58% | -24.72% | 93.40% | |
| Cost of Revenue | 167.89 | 156.5 | 81.61 | 44.88 | 33.15 | 25.54 | |
| Gross Profit | -130.99 | -129.52 | -67.15 | -33.18 | -22.76 | -11.74 | |
| Selling, General & Admin | 65.46 | 60.43 | 49.51 | 32.44 | 29.2 | 14.56 | |
| Operating Expenses | 65.46 | 60.43 | 49.51 | 32.44 | 29.2 | 14.56 | |
| Operating Income | -196.44 | -189.95 | -116.65 | -65.62 | -51.96 | -26.3 | |
| Interest Expense | -2.5 | -3.26 | -3.34 | -2.98 | -0.46 | - | |
| Interest & Investment Income | 30.26 | 14 | 5.76 | 0.12 | 0.68 | 0.81 | |
| Other Non Operating Income (Expenses) | - | - | - | - | - | -5.38 | |
| Pretax Income | -169.64 | -179.21 | -114.24 | -68.48 | -51.73 | -30.86 | |
| Income Tax Expense | -3.36 | 1.46 | -1.52 | -1.66 | -0.72 | -0.25 | |
| Net Income | -166.28 | -180.66 | -112.72 | -66.82 | -51.01 | -30.61 | |
| Net Income to Common | -166.28 | -180.66 | -112.72 | -66.82 | -51.01 | -30.61 | |
| Shares Outstanding (Basic) | 52 | 36 | 30 | 25 | 19 | 11 | |
| Shares Outstanding (Diluted) | 52 | 36 | 30 | 25 | 19 | 11 | |
| Shares Change (YoY) | 59.12% | 20.00% | 18.35% | 30.90% | 73.34% | 2416.82% | |
| EPS (Basic) | -3.23 | -5.08 | -3.80 | -2.67 | -2.66 | -2.77 | |
| EPS (Diluted) | -3.23 | -5.08 | -3.80 | -2.67 | -2.66 | -2.77 | |
| Free Cash Flow | - | -63.56 | -105.1 | -16.82 | -18.99 | -30.17 | |
| Free Cash Flow Per Share | - | -1.79 | -3.54 | -0.67 | -0.99 | -2.73 | |
| Gross Margin | - | - | - | -283.69% | -219.05% | -85.06% | |
| Operating Margin | -532.40% | -704.13% | -806.56% | -560.98% | -500.10% | -190.56% | |
| Profit Margin | -450.64% | -669.72% | -779.35% | -571.25% | -490.95% | -221.78% | |
| Free Cash Flow Margin | - | -235.61% | -726.67% | -143.83% | -182.76% | -218.59% | |
| EBITDA | -189.87 | -183.4 | -112.96 | -64.21 | -50.68 | -25.34 | |
| EBITDA Margin | - | - | - | - | - | -183.60% | |
| D&A For EBITDA | 6.57 | 6.55 | 3.69 | 1.41 | 1.28 | 0.96 | |
| EBIT | -196.44 | -189.95 | -116.65 | -65.62 | -51.96 | -26.3 | |
| EBIT Margin | - | - | - | - | - | -190.56% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.